Total Funding
90
64
Total FundingGrant raised
Growth Score
-6 pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39817
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.
Patrick Griffin: Treasurer Board Of DirectorsPast Role: Ember Therapeutics, Co-founder and SAB member- Patrick Griffin: Chief Scientific Officer & Co-FounderPast Role: Ember Therapeutics, Co-Founder
About the Company
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders. The company specializes in molecular machines that turn energy into mechanical work inside cells, enabling doctors to treat various disease states, including cancer, and focuses on developing innovative drugs that target cellular
motor proteins.
